110 related articles for article (PubMed ID: 1386050)
1. Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse.
Calmus Y; Weill B; Ozier Y; Chéreau C; Houssin D; Poupon R
Gastroenterology; 1992 Aug; 103(2):617-21. PubMed ID: 1386050
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes.
Calmus Y; Guechot J; Podevin P; Bonnefis MT; Giboudeau J; Poupon R
Hepatology; 1992 Sep; 16(3):719-23. PubMed ID: 1505915
[TBL] [Abstract][Full Text] [Related]
3. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
4. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of chenodeoxycholic and ursodeoxycholic acids on expression of procoagulant activity by human monocytes.
Calmus Y; Podevin P; Robert A; Poupon R
J Hepatol; 1994 Apr; 20(4):466-72. PubMed ID: 8051383
[TBL] [Abstract][Full Text] [Related]
6. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
Xiao ZL; Biancani P; Carey MC; Behar J
Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
[TBL] [Abstract][Full Text] [Related]
7. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
Suwannaroj S; Lagoo A; McMurray RW
Lupus; 2001; 10(8):562-7. PubMed ID: 11530998
[TBL] [Abstract][Full Text] [Related]
8. A novel, protective role of ursodeoxycholate in bile-induced pancreatic ductal injury.
Katona M; Hegyi P; Kui B; Balla Z; Rakonczay Z; Rázga Z; Tiszlavicz L; Maléth J; Venglovecz V
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G193-204. PubMed ID: 26608189
[TBL] [Abstract][Full Text] [Related]
9. Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage.
Walker S; Rudolph G; Raedsch R; Stiehl A
Gastroenterology; 1992 Mar; 102(3):810-5. PubMed ID: 1537519
[TBL] [Abstract][Full Text] [Related]
10. The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells.
Lacaille F; Paradis K
Hepatology; 1993 Jul; 18(1):165-72. PubMed ID: 8325607
[TBL] [Abstract][Full Text] [Related]
11. Effects of bile acids on the humoral immune response: a mechanistic approach.
Correia L; Podevin P; Borderie D; Verthier N; Montet JC; Feldmann G; Poupon R; Weill B; Calmus Y
Life Sci; 2001 Oct; 69(20):2337-48. PubMed ID: 11681621
[TBL] [Abstract][Full Text] [Related]
12. Regulation of alkaline phosphatase gene expression in human hepatoma cells by bile acids.
Khan KN; Tsutsumi T; Nakata K; Nakao K; Kato Y; Nagataki S
J Gastroenterol Hepatol; 1998 Jun; 13(6):643-50. PubMed ID: 9715409
[TBL] [Abstract][Full Text] [Related]
13. Effects of bile acids on iodide uptake and deoxyribonucleic acid synthesis in porcine thyroid cells in primary culture.
Kanri R; Takiyama Y; Makino I
Thyroid; 1996 Oct; 6(5):467-74. PubMed ID: 8936674
[TBL] [Abstract][Full Text] [Related]
14. Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.
Salvioli G; Salati R
Gut; 1979 Aug; 20(8):698-704. PubMed ID: 488763
[TBL] [Abstract][Full Text] [Related]
15. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
[TBL] [Abstract][Full Text] [Related]
16. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
Tint GS; Salen G; Shefer S
Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
[TBL] [Abstract][Full Text] [Related]
17. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
von Bergmann K; Epple-Gutsfeld M; Leiss O
Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
[TBL] [Abstract][Full Text] [Related]
18. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
Barone M; Francavilla A; Polimeno L; Ierardi E; Romanelli D; Berloco P; Di Leo A; Panella C
Hepatology; 1996 May; 23(5):1159-66. PubMed ID: 8621149
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
Iwaki T; Ishizaki K; Kinoshita S; Tanaka H; Fukunari A; Tsurufuji M; Imada T
World J Gastroenterol; 2007 Oct; 13(37):5003-8. PubMed ID: 17854144
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
